Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
TherapeuticsMD
(NASDAQ:TXMD)
Intraday
$2.17
0.03
[1.40%]
After-Hours
$2.17
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.17
0.03
[1.40%]
At close: May 17
$2.17
0
[0.00%]
After Hours: 7:15PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for TherapeuticsMD Stock (NASDAQ:TXMD)
TherapeuticsMD Stock (NASDAQ: TXMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, May 10, 2024
TherapeuticsMD Q1 EPS $(0.07) Up From $(0.24) YoY
Benzinga Newsdesk
-
May 10, 2024, 4:07PM
Monday, March 04, 2024
5 Value Stocks In The Healthcare Sector
Benzinga Insights
-
Mar 4, 2024, 9:44AM
Monday, February 12, 2024
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
-
Feb 12, 2024, 9:43AM
Monday, December 25, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
-
Dec 25, 2023, 9:43AM
Monday, November 27, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
-
Nov 27, 2023, 9:43AM
Friday, November 17, 2023
2.00M Reasons To Be Bullish On TherapeuticsMD Stock
Benzinga Insights
-
Nov 17, 2023, 10:01AM
Tuesday, November 14, 2023
TherapeuticsMD Q3 EPS $(0.13) Misses $(0.05) Estimate
Benzinga Newsdesk
-
Nov 14, 2023, 4:57PM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Thursday, August 17, 2023
Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Maintains $5 Price Target
Benzinga Newsdesk
-
Aug 17, 2023, 11:48AM
Monday, August 14, 2023
TherapeuticsMD Q2 EPS $(0.24) Misses $(0.07) Estimate, Sales from Cont Ops $400.00K Miss $500.00K Estimate
Benzinga Newsdesk
-
Aug 14, 2023, 6:58AM
Friday, June 30, 2023
1.15M Reasons To Be Bullish On TherapeuticsMD Stock
Benzinga Insights
-
Jun 30, 2023, 11:04AM
Monday, June 05, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
-
Jun 5, 2023, 10:43AM
Friday, January 27, 2023
Cigna Is Out With A New Coverage Policy Stating That TherapeuticsMD Imvexxy Is Now Covered. (Effective 1/1/24 But Just Disclosed).
Happy Mohamed
-
Jan 27, 2023, 11:27AM
Wednesday, January 18, 2023
TherapeuticsMD Says Terminated Certain Amended, Restated Employment Agreement Between Co., Michael Donegan
Michael Horton
-
Jan 18, 2023, 5:03PM
Wednesday, January 11, 2023
Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target
Benzinga Newsdesk
-
Jan 11, 2023, 7:45AM
Monday, January 02, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Jan 2, 2023, 4:30PM
Monday, December 05, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 5, 2022, 4:32PM
Monday, November 14, 2022
TherapeuticsMD Q3 Sales $20.92M Down From $25.41M YoY
Benzinga Newsdesk
-
Nov 14, 2022, 5:03PM
Monday, October 03, 2022
TherapeuticsMD Announces $7M Private Placement
Benzinga Newsdesk
-
Oct 3, 2022, 6:51AM
Tuesday, September 27, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Sep 27, 2022, 5:44PM
Monday, September 12, 2022
TherapeuticsMD Appoints Dr. Brian Bernick And Mr. Mark Glickman As Interim Co-Chief Executive Officers
Benzinga Newsdesk
-
Sep 12, 2022, 6:50AM
Friday, September 09, 2022
Looking Into TherapeuticsMD's Return On Capital Employed
Benzinga Insights
-
Sep 9, 2022, 10:19AM
Wednesday, September 07, 2022
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Lisa Levin
-
Sep 7, 2022, 5:16AM
Tuesday, September 06, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Sep 6, 2022, 1:43PM
Monday, August 15, 2022
Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday
Lisa Levin
-
Aug 15, 2022, 1:02PM
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Aug 15, 2022, 12:05PM
Ten Stocks Trending on Discord for Monday August 15, 2022 Premarket: TISI, VEEE, PSTV, BBBY, HLBZ, AGFY, UBX, TXMD, VRDN, XSPA
Charles Gross
-
Aug 15, 2022, 9:47AM
TherapeuticsMD shares are trading higher after the company reported Q2 EPS results were higher year over year and better-than-expected Q2 sales results.
Benzinga Newsdesk
-
Aug 15, 2022, 9:45AM
Why TherapeuticsMD Stock Is Trading Higher
Adam Eckert
-
Aug 15, 2022, 9:31AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Aug 15, 2022, 8:17AM
TherapeuticsMD: Q2 Earnings Insights
Benzinga Insights
-
Aug 15, 2022, 7:55AM
TherapeuticsMD Q2 EPS $12.39 Up From $(5.41) YoY, Sales $28.56M Beat $23.20M Estimate
Benzinga Newsdesk
-
Aug 15, 2022, 6:51AM
Earnings Scheduled For August 15, 2022
Benzinga Insights
-
Aug 15, 2022, 4:30AM
Friday, August 12, 2022
TherapeuticsMD Earnings Preview
Benzinga Insights
-
Aug 12, 2022, 12:16PM
Tuesday, August 02, 2022
$15 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are Buying
Lisa Levin
-
Aug 2, 2022, 9:04AM
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
Lisa Levin
-
Aug 2, 2022, 5:01AM
Monday, August 01, 2022
U.S. Stocks Turn Negative; Dow Drops Over 100 Points
Lisa Levin
-
Aug 1, 2022, 2:39PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Aug 1, 2022, 1:40PM
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Aug 1, 2022, 12:49PM
U.S. Stocks Turn Higher; Crude Oil Tumbles
Lisa Levin
-
Aug 1, 2022, 12:21PM
TherapeuticsMD shares are trading higher after the company announced it has received a $15 million private investment from Rubric Capital Management.
Benzinga Newsdesk
-
Aug 1, 2022, 10:58AM
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
Vandana Singh
-
Aug 1, 2022, 9:03AM
TherapeuticsMD Secures $15M Equity Investment From Rubric Capital
Benzinga Newsdesk
-
Aug 1, 2022, 6:50AM
Friday, July 29, 2022
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Lisa Levin
-
Jul 29, 2022, 5:55AM
Thursday, July 28, 2022
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jul 28, 2022, 1:38PM
Friday, July 15, 2022
HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On 'Unclear Path'
Vandana Singh
-
Jul 15, 2022, 1:34PM
Thursday, July 14, 2022
TherapeuticsMD Granted European Patented #EP2861072 Titled "NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES (FOR ESTROGEN AND PROGESTERONE)"
Benzinga Newsdesk
-
Jul 14, 2022, 2:29PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jul 14, 2022, 8:16AM
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
Lisa Levin
-
Jul 14, 2022, 5:58AM
Wednesday, July 13, 2022
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Jul 13, 2022, 3:00PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch